Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2014; 20(4): 1061-1066
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.1061
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.1061
Figure 1 Flow of the study.
A total of 1197 patients were investigated in the study period, and 573 patients in Group A [without proton pump inhibitors (PPI) pretreatment] and 517 in Group B (with PPI pretreatment) were included in the analysis. Patients in Group B were reclassified into three groups based on the duration of PPI pretreatment: Group B-1 (3-14 d), Group B-2 (15-55 d) and Group B-3 (≥ 56 d). H2RA: H2 receptor antagonist.
-
Citation: Yoon SB, Park JM, Lee JY, Baeg MK, Lim CH, Kim JS, Cho YK, Lee IS, Kim SW, Choi MG. Long-term pretreatment with proton pump inhibitor and
Helicobacter pylori eradication rates. World J Gastroenterol 2014; 20(4): 1061-1066 - URL: https://www.wjgnet.com/1007-9327/full/v20/i4/1061.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i4.1061